Ernexa Therapeutics (ERNAW) Change in Taxes (2010 - 2020)
Ernexa Therapeutics' (ERNAW) quarterly Change in Taxes came in at $21000.0 in Q4 2020, up 800.0% YoY from $2333.3 in Q1 2020, and up 200.0% on a QoQ basis from $7000.0 in Q1 2020.
Powered by 
Analysis
Ernexa Therapeutics (ERNAW) Change in Taxes (2010 - 2020) Analysis & Trends
Ernexa Therapeutics (ERNAW) has 11 years of Change in Taxes data on file, last reported at $21000.0 in Q4 2020.
- Quarterly Change in Taxes rose 800.0% year-over-year to $21000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $39000.0 (up 3800.0% YoY) and the FY2020 annual result came in at $5000.0, up 400.0% from the prior year.
- Change in Taxes climbed to $21000.0 in Q4 2020, from $7000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $21000.0 in Q4 2020 to a low of -$34000.0 in Q4 2018.
- A 5-year average of $500.0 and a median of $7000.0 in 2018 frame the typical range for Change in Taxes.
- Annual changes were most pronounced in 2017 — Change in Taxes slumped 2100.0% — and 2020, when it surged 800.0%.
- Tracing ERNAW's Change in Taxes over 5 years: stood at -$7000.0 in 2016, then soared by 257.14% to $11000.0 in 2017, then sank by 409.09% to -$34000.0 in 2018, then soared by 91.18% to -$3000.0 in 2019, then surged by 800.0% to $21000.0 in 2020.
- The last three Change in Taxes figures came in at $21000.0 (Q4 2020), $7000.0 (Q1 2020), and -$3000.0 (Q4 2019), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Ernexa Therapeutics | 67,312.70 | 67,312.70 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 21,000.00 |
| Mar 31, 2020 | 7,000.00 |
| Dec 31, 2019 | -3,000.00 |
| Sep 30, 2019 | 14,000.00 |
| Jun 30, 2019 | -20,000.00 |
| Mar 31, 2019 | 10,000.00 |
| Dec 31, 2018 | -34,000.00 |
| Sep 30, 2018 | 10,000.00 |
| Jun 30, 2018 | 7,000.00 |
| Mar 31, 2018 | 7,000.00 |
| Dec 31, 2017 | 11,000.00 |
| Sep 30, 2017 | 10,000.00 |
| Jun 30, 2017 | 10,000.00 |
| Mar 31, 2017 | -22,000.00 |
| Dec 31, 2016 | -7,000.00 |
| Sep 30, 2016 | -2,000.00 |
| Jun 30, 2016 | -9,000.00 |
| Mar 31, 2016 | -1,000.00 |
| Dec 31, 2015 | -15,000.00 |
| Sep 30, 2015 | -30,000.00 |